Related Experiment Video
Updated: Feb 28, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Patient-Driven Second Opinions in Oncology: A Systematic Review
Marij A Hillen1, Niki M Medendorp2, Joost G Daams3
1Department of Medical Psychology, Amsterdam, The Netherlands M.A.Hillen@amc.uva.nl.
Cancer patients increasingly seek second opinions for various reasons, including a need for certainty and better communication. However, the overall benefits and optimal facilitation of this process require further investigation.
Area of Science:
- Oncology
- Patient-centered care
- Health services research
Background:
- Patient-driven second opinions in oncology are rising.
- The desirability and impact of this trend are not well understood.
Purpose of the Study:
- To systematically review evidence on patient motivations for seeking second opinions in oncology.
- To examine the frequency, evolution, and consequences of these requests on oncological practice.
Main Methods:
- Systematic review of peer-reviewed articles on patient-initiated second opinions in oncology.
- Searched databases using terms: "cancer," "second opinion," and "self-initiated."
- Two researchers performed selection, data extraction, and quality assessment.
Main Results:
- Included 25 studies (4 qualitative, 1 mixed, 20 quantitative).
- Second opinion seeking rates varied widely (1%-88%), with higher education being a consistent correlate.
- Primary patient motivations included need for certainty, trust issues, communication dissatisfaction, and desire for more personalized information.
- Discrepancies between first and second opinions ranged from 2%-51%.
Conclusions:
- The benefits of cancer patient second opinions remain unclear.
- Studies vary significantly in methodology and quality.
- Further research is needed to understand consequences and guide patients/physicians, with practical recommendations for oncologists provided.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Targeted Cancer Therapies
There are several types of targeted therapies against...
Standards of Care II
Cancer Survival Analysis
